working to help defeat malaria – part of an overall network of 400 partners in 50 countries
of injectable artesunate for severe malaria delivered since 2010, saving the lives of over 1m additional vulnerable children compared with quinine treatment
shipped free of charge to scientists around the world to boost drug discovery for neglected diseases
Learn about MMV's activities in the context of COVID-19.
Discover how enhancing African manufacturing capacity can increase IPTp coverage in this Q&A in French and English.
Read more about MMV's initiative to combat malaria in women who are of reproductive potential, pregnant or breastfeeding.
There are currently no upcoming events.